Dexcom, Inc.
12.52xPrice / tangible book
Market cap
$33.18B
Tangible equity
$2.65B
Price / tangible book
12.52x
Price / book
12.08x
Return on equity
30.5%
Return on assets
13.2%
Efficiency ratio
—
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $33.18B · View financials
Snapshot Sep 4, 4:00 PM ET
Latest annual filing · View financials
Decision snapshot: DXCM stock price vs JPM: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at JPM's multiple
Needs JPM P/E.
Implied fair value · at DXCM's multiple
Needs EPS (TTM).
Metric by metric
Snapshot Sep 4, 4:00 PM ET
Filter, sort, and scan the equity metrics that matter most for banks: book value, tangible book, returns, and operating efficiency.
Lower is better
Lower is better
Higher is better
Higher is better
Lower is better
Statements
Bank-focused income statement and equity metrics aligned to the reporting windows.
SEC periods: DXCM FY 2025 (ended Dec 31, 2025) · JPM Latest annual filing. Fiscal years are not aligned.
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Tangible book and profitability anchor a bank, not enterprise value.
Deposits and cash-like balances distort enterprise value for banks, so this section reads equity value, tangible book and profitability instead.
Price / tangible book
Market cap
$33.18B
Tangible equity
$2.65B
Price / tangible book
12.52x
Price / book
12.08x
Return on equity
30.5%
Return on assets
13.2%
Efficiency ratio
—
Price / book
Market cap
—
Tangible equity
—
Price / tangible book
—
Price / book
—
Return on equity
—
Return on assets
—
Efficiency ratio
—
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
DEXCOM, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
JPMORGAN CHASE & CO · implied price per share
Bank model off — standard DCF modelling is disabled for financial institutions.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
JPM · not enough data.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
1.21x
—
Net debt / EBITDA
Leverage against operating earnings
1.81x
—
Cash and equivalents
Liquid reserves on the balance sheet
$917.70M
—
Total debt
Interest-bearing obligations outstanding
$3.32B
—
Comparable set
Where the pair sits against the wider banking comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
ABBOTT LABORATORIES
DXCM vs ABT
Medtronic plc
DXCM vs MDT
BECTON DICKINSON & CO
DXCM vs BDX
Bank of America Corporation
DXCM vs BAC
Citigroup Inc.
DXCM vs C
Wells Fargo & Company
DXCM vs WFC
The Goldman Sachs Group, Inc.
DXCM vs GS
Morgan Stanley
DXCM vs MS
PNC FINANCIAL SERVICES GROUP, INC.
DXCM vs PNC
US BANCORP \DE\
DXCM vs USB
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.